Medmira (47M) Ratios
Medmira Ratios
DE:47M's free cash flow for Q3 2026 was $-150.63K. For the 2026 fiscal year, DE:47M's free cash flow was increased by $0.00 and operating cash flow was $-150.63K. See a summary of the company’s cash flow.
| Ratios | Oct 25 | Oct 24 | Oct 23 | Oct 22 | Oct 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.07 | 0.18 | 0.11 | 0.12 | 0.09 |
| Quick Ratio | 0.06 | 0.17 | 0.10 | 0.10 | 0.08 |
| Cash Ratio | 0.00 | 0.10 | 0.00 | 0.00 | -0.13 |
| Solvency Ratio | -0.16 | -0.13 | -0.13 | -0.10 | -0.02 |
| Operating Cash Flow Ratio | -0.14 | -0.14 | -0.08 | -0.13 | -0.03 |
| Short-Term Operating Cash Flow Coverage | -0.50 | -0.48 | -0.21 | -0.31 | -0.05 |
| Net Current Asset Value | $ -24.64M | $ -20.43M | $ -16.99M | $ -14.53M | $ -18.04M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 2.91 | 1.58 | 2.54 | 2.17 | 2.97 |
| Debt-to-Equity Ratio | -0.47 | -0.53 | -0.62 | -0.67 | -0.73 |
| Debt-to-Capital Ratio | -0.90 | -1.13 | -1.61 | -2.05 | -2.75 |
| Long-Term Debt-to-Capital Ratio | -0.10 | -0.05 | -0.08 | -0.00 | -0.00 |
| Financial Leverage Ratio | -0.16 | -0.34 | -0.24 | -0.31 | -0.25 |
| Debt Service Coverage Ratio | -0.42 | -0.31 | -0.22 | -0.19 | 0.02 |
| Interest Coverage Ratio | -3.33 | -2.92 | -2.20 | -2.63 | -0.28 |
| Debt to Market Cap | 0.15 | 0.11 | 0.12 | 0.07 | 0.12 |
| Interest Debt Per Share | 0.02 | 0.02 | 0.01 | 0.01 | 0.02 |
| Net Debt to EBITDA | -3.42 | -3.50 | -5.87 | -7.74 | 74.69 |
| Profitability Margins | |||||
| Gross Profit Margin | -411.73% | 54.90% | -100.55% | 31.93% | 80.29% |
| EBIT Margin | -1433.57% | -592.36% | -413.88% | -134.39% | -1.05% |
| EBITDA Margin | -1301.53% | -517.33% | -364.66% | -112.09% | 8.64% |
| Operating Profit Margin | -1492.56% | -623.65% | -449.52% | -152.63% | -8.59% |
| Pretax Profit Margin | -1881.18% | -806.25% | -618.61% | -192.37% | -31.51% |
| Net Profit Margin | -1881.18% | -806.25% | -618.61% | -192.37% | -31.51% |
| Continuous Operations Profit Margin | -1881.18% | -806.25% | -618.61% | -192.37% | -31.51% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 126.04% | 129.28% | 137.61% | 126.04% | 366.82% |
| Return on Assets (ROA) | -122.89% | -54.80% | -73.27% | -47.83% | -17.37% |
| Return on Equity (ROE) | 20.05% | 18.44% | 17.80% | 14.82% | 4.30% |
| Return on Capital Employed (ROCE) | 19.58% | 17.29% | 16.10% | 14.10% | 1.36% |
| Return on Invested Capital (ROIC) | 30.28% | 30.36% | 33.75% | 35.82% | 4.40% |
| Return on Tangible Assets | -122.89% | -54.80% | -73.27% | -47.83% | -17.37% |
| Earnings Yield | -8.11% | -5.03% | -4.26% | -2.07% | -0.86% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.18 | 0.31 | 0.30 | 0.70 | 1.71 |
| Payables Turnover | 0.42 | 0.07 | 0.27 | 0.24 | 0.16 |
| Inventory Turnover | 5.97 | 1.05 | 4.76 | 3.21 | 1.79 |
| Fixed Asset Turnover | 0.12 | 0.17 | 0.22 | 0.44 | 0.93 |
| Asset Turnover | 0.07 | 0.07 | 0.12 | 0.25 | 0.55 |
| Working Capital Turnover Ratio | -0.01 | -0.03 | -0.03 | -0.07 | -0.14 |
| Cash Conversion Cycle | 1198.59 | -3801.17 | -91.54 | -909.95 | -1914.62 |
| Days of Sales Outstanding | 2000.78 | 1178.34 | 1204.58 | 524.83 | 212.87 |
| Days of Inventory Outstanding | 61.11 | 349.22 | 76.76 | 113.74 | 203.58 |
| Days of Payables Outstanding | 863.31 | 5328.72 | 1372.89 | 1548.53 | 2331.06 |
| Operating Cycle | 2061.90 | 1527.56 | 1281.34 | 638.58 | 416.44 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Free Cash Flow Per Share | -0.00 | -0.01 | -0.00 | -0.00 | -0.00 |
| Dividend Paid and CapEx Coverage Ratio | -421.19 | -3.96 | -1000.59 | -27.02 | -13.81 |
| Capital Expenditure Coverage Ratio | -421.19 | -3.96 | -1000.59 | -27.02 | -13.81 |
| Operating Cash Flow Coverage Ratio | -0.29 | -0.31 | -0.14 | -0.23 | -0.04 |
| Operating Cash Flow to Sales Ratio | -13.08 | -7.12 | -2.93 | -1.98 | -0.24 |
| Free Cash Flow Yield | -5.65% | -5.57% | -2.02% | -2.21% | -0.69% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -12.31 | -19.87 | -23.46 | -48.31 | -116.90 |
| Price-to-Sales (P/S) Ratio | 232.06 | 160.22 | 145.12 | 92.93 | 36.84 |
| Price-to-Book (P/B) Ratio | -2.47 | -3.66 | -4.18 | -7.16 | -5.02 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -17.70 | -17.96 | -49.46 | -45.29 | -145.97 |
| Price-to-Operating Cash Flow Ratio | -17.74 | -22.50 | -49.51 | -46.97 | -156.55 |
| Price-to-Earnings Growth (PEG) Ratio | -0.35 | -0.76 | -0.58 | -0.28 | 1.73 |
| Enterprise Value Multiple | -21.25 | -34.47 | -45.67 | -90.65 | 501.02 |
| Enterprise Value | 66.50M | 73.57M | 72.03M | 96.75M | 92.84M |
| EV to EBITDA | -21.25 | -34.47 | -45.67 | -90.65 | 501.02 |
| EV to Sales | 276.52 | 178.31 | 166.53 | 101.61 | 43.29 |
| EV to Free Cash Flow | -21.09 | -19.99 | -56.76 | -49.52 | -171.55 |
| EV to Operating Cash Flow | -21.14 | -25.04 | -56.82 | -51.35 | -183.97 |
| Tangible Book Value Per Share | -0.03 | -0.03 | -0.02 | -0.02 | -0.02 |
| Shareholders’ Equity Per Share | -0.03 | -0.03 | -0.02 | -0.02 | -0.02 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | -0.09 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.01 | -0.00 | -0.00 | -0.00 | -0.00 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.31 | 1.36 | 1.49 | 1.43 | 30.03 |
| Research & Development to Revenue | 5.45 | 1.16 | 1.09 | 0.20 | 0.17 |
| SG&A to Revenue | 6.68 | 2.90 | 1.95 | 0.77 | 0.23 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.70 | 0.88 | 0.47 | 1.03 | 0.75 |
Currency in CAD
